SCHEMBL7016353

SCHEMBL7016353

CN1CCC(c2c[nH]c3ccc(-c4ccc(NC(=O)c5ccco5)cc4)cc23)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1D P28221 12/20 0.62
HTR1B P28222 12/20 0.62
HTR1A P08908 3/20 0.62
HTR1F P30939 3/20 0.62
NOS3 P29474 3/20 0.58
NOS1 P29475 3/20 0.58
NOS2 P35228 1/20 0.58
HTR6 P50406 1/20 0.54
APP P05067 1/20 0.51
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
THPO P40225 1/20 0.50
PTPN2 P17706 1/20 0.49
PTPN1 P18031 1/20 0.49
PTPN6 P29350 1/20 0.49
PTPN11 Q06124 1/20 0.49
MAPT P10636 1/20 0.48
BLM P54132 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL7481861 0.88 HTR1D (0.62) HTR1DHTR1BHTR1AHTR1FNOS3
Fumaric Acid SCHEMBL7481870 0.88 HTR1D (0.62) HTR1DHTR1BHTR1AHTR1FNOS3
SCHEMBL7009508 0.83 HTR1D (0.83) HTR1DHTR1BHTR1AHTR1FHTR6
SCHEMBL7480742 0.83 HTR1D (0.61) HTR1DHTR1BHTR1AHTR1F
SCHEMBL7478148 0.83 HTR1D (0.55) HTR1DHTR1BHTR1AHTR1FNOS3
SCHEMBL7479138 0.83 HTR1D (0.59) HTR1DHTR1BHTR1AHTR1F
SCHEMBL7484610 0.83 HTR1D (0.55) HTR1DHTR1BHTR1AHTR1FNOS3
SCHEMBL1122273 0.82 HTR1D (0.64) HTR1DHTR1BHTR1AHTR1FNOS3
SCHEMBL7017007 0.81 HTR1D (0.85) HTR1DHTR1BHTR1AHTR1F
SCHEMBL7486909 0.81 HTR1D (0.62) HTR1DHTR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1089993-B1 5-HT1F AGONISTS LILLY CO ELI (US) 2003-10-22 EP disclosed
US-6358972-B1 FOR THERAPY OF MIGRAINE ELI LILLY AND COMPANY 2002-03-19 US disclosed